Kinnate Biopharma Inc. Quarterly Operating Leases, Future Minimum Payments Due in USD from Q4 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
Summary
Kinnate Biopharma Inc. quarterly Operating Leases, Future Minimum Payments Due history and growth rate from Q4 2021 to Q4 2022.
  • Kinnate Biopharma Inc. Operating Leases, Future Minimum Payments Due for the quarter ending December 31, 2022 was $5.16M, unchanged year-over-year.
Operating Leases, Future Minimum Payments Due, Quarterly (USD)
Operating Leases, Future Minimum Payments Due, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $5.16M $0 0% Dec 31, 2022 10-K 2023-03-15
Q4 2021 $5.16M Dec 31, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.